Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Schinkel, J. Jonker (2003)
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.Advanced drug delivery reviews, 55 1
A. Rothnie, D. Theron, Loredana Soceneantu, Catherine Martin, M. Traikia, G. Berridge, C. Higgins, P. Devaux, R. Callaghan (2001)
The importance of cholesterol in maintenance of P-glycoprotein activity and its membrane perturbing influenceEuropean Biophysics Journal, 30
I. Lelong, A. Guzikowski, R. Haugland, I. Pastan, M. Gottesman, M. Willingham (1991)
Fluorescent verapamil derivative for monitoring activity of the multidrug transporter.Molecular pharmacology, 40 4
O. Lowry, N. Rosebrough, A. Farr, R. Randall (1951)
Protein measurement with the Folin phenol reagent.The Journal of biological chemistry, 193 1
R. O’Connor, C. Liu, C. Ferris, B. Guild, B. Teicher, C. Corvi, Y. Liu, R. Arceci, V. Goldmacher, J. Lambert, W. Blättler (1995)
Anti-B4-blocked ricin synergizes with doxorubicin and etoposide on multidrug-resistant and drug-sensitive tumors.Blood, 86 11
B. Razani, S. Woodman, M. Lisanti (2002)
Caveolae: From Cell Biology to Animal PhysiologyPharmacological Reviews, 54
T. Saeki, A. Shimabuku, K. Ueda, T. Komano (1992)
Specific drug binding by purified lipid-reconstituted P-glycoprotein: dependence on the lipid composition.Biochimica et biophysica acta, 1107 1
E. London, Deborah Brown (2000)
Insolubility of lipids in triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts).Biochimica et biophysica acta, 1508 1-2
Y. Romsicki, F. Sharom (2001)
Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter.Biochemistry, 40 23
K. Song, Philipp Scherer, Zhaolan Tang, T. Okamoto, Shengwen Li, M. Chafel, C. Chu, D. Kohtz, M. Lisanti (1996)
Expression of Caveolin-3 in Skeletal, Cardiac, and Smooth Muscle CellsThe Journal of Biological Chemistry, 271
H. Sprong, P. Sluijs, G. Meer (2001)
How proteins move lipids and lipids move proteinsNature Reviews Molecular Cell Biology, 2
(2000)
Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains, 39
K. Simons, D. Toomre (2000)
Lipid rafts and signal transductionNature Reviews Molecular Cell Biology, 1
L. Pike, L. Casey (2002)
Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking.Biochemistry, 41 32
Kiyokazu Yunomae, H. Arima, F. Hirayama, K. Uekama (2003)
Involvement of cholesterol in the inhibitory effect of dimethyl‐β‐cyclodextrin on P‐glycoprotein and MRP2 function in Caco‐2 cellsFEBS Letters, 536
Deborah Brown, E. London (2000)
Structure and Function of Sphingolipid- and Cholesterol-rich Membrane Rafts*The Journal of Biological Chemistry, 275
J. Asperen, O. Tellingen, J. Beijnen (1998)
The pharmacological role of P-glycoprotein in the intestinal epithelium.Pharmacological research, 37 6
F. Sinicrope, P. Dudeja, P. Dudeja, B. Bissonnette, A. Safa, T. Brasitus (1992)
Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles.The Journal of biological chemistry, 267 35
J. Pallarés‐Trujillo, C. Domènech, M. Grau‐Oliete, M. Rivera‐Fillat (1993)
Role of cell cholesterol in modulating vincristine uptake and resistanceInternational Journal of Cancer, 55
E. Smart, R. Anderson (2002)
Alterations in membrane cholesterol that affect structure and function of caveolae.Methods in enzymology, 353
Michael Fastenberg, H. Shogomori, Xiaoliang Xu, Deborah Brown, E. London (2003)
Exclusion of a transmembrane-type peptide from ordered-lipid domains (rafts) detected by fluorescence quenching: extension of quenching analysis to account for the effects of domain size and domain boundaries.Biochemistry, 42 42
A. Pohl, H. Lage, P. Müller, T. Pomorski, A. Herrmann (2002)
Transport of phosphatidylserine via MDR1 (multidrug resistance 1)P-glycoprotein in a human gastric carcinoma cell line.The Biochemical journal, 365 Pt 1
G. Gimpl, Katja Burger, Falk Fahrenholz (1997)
Cholesterol as modulator of receptor function.Biochemistry, 36 36
M. Ghetie, R. Marches, Stephanie Kufert, E. Vitetta (2004)
An anti-CD19 antibody inhibits the interaction between P-glycoprotein (P-gp) and CD19, causes P-gp to translocate out of lipid rafts, and chemosensitizes a multidrug-resistant (MDR) lymphoma cell line.Blood, 104 1
J. Troost, Nadine Albermann, Walter Haefeli, J. Weiss (2004)
Cholesterol modulates P-glycoprotein activity in human peripheral blood mononuclear cells.Biochemical and biophysical research communications, 316 3
M. Liscovitch, Y. Lavie (2000)
Multidrug resistance: a role for cholesterol efflux pathways?Trends in biochemical sciences, 25 11
J. Weiss, C. Kerpen, H. Lindenmaier, Sven-Maria Dormann, W. Haefeli (2003)
Interaction of Antiepileptic Drugs with Human P-Glycoprotein in VitroJournal of Pharmacology and Experimental Therapeutics, 307
A. Schinkel, J. Smit, O. Tellingen, J. Beijnen, E. Wagenaar, L. Deemter, C. Mol, M. Valk, E. Robanus-Maandag, H. Riele, A. Berns, P. Borst (1994)
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsCell, 77
M. Gottesman, T. Fojo, S. Bates (2002)
Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2
J. Weiss, Sven-Maria Dormann, M. Martin-Facklam, C. Kerpen, Nahal Ketabi-Kiyanvash, W. Haefeli (2003)
Inhibition of P-Glycoprotein by Newer AntidepressantsJournal of Pharmacology and Experimental Therapeutics, 305
H. Kusuhara, H. Suzuki, Y. Sugiyama (1998)
The role of P-glycoprotein and canalicular multispecific organic anion transporter in the hepatobiliary excretion of drugs.Journal of pharmaceutical sciences, 87 9
G. Meer (2002)
The Different Hues of Lipid RaftsScience, 296
Y. Lavie, G. Fiucci, M. Liscovitch (1998)
Up-regulation of Caveolae and Caveolar Constituents in Multidrug-resistant Cancer Cells*The Journal of Biological Chemistry, 273
Uwe Klein, G. Gimpl, Falk Fahrenholz (1995)
Alteration of the myometrial plasma membrane cholesterol content with beta-cyclodextrin modulates the binding affinity of the oxytocin receptor.Biochemistry, 34 42
A. Garrigues, A. Escargueil, S. Orlowski (2002)
The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membraneProceedings of the National Academy of Sciences of the United States of America, 99
W. Chiou, Sang Chung, Ta-Chen Wu (2000)
Potential Role of P-Glycoprotein in Affecting Hepatic Metabolism of DrugsPharmaceutical Research, 17
A. Schinkel, E. Wagenaar, C. Mol, L. Deemter (1996)
P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.The Journal of clinical investigation, 97 11
Y. Romsicki, F. Sharom (1999)
The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter.Biochemistry, 38 21
R. Regev, Y. Assaraf, G. Eytan (1999)
Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells.European journal of biochemistry, 259 1-2
H. Arima, Kiyokazu Yunomae, F. Hirayama, K. Uekama (2001)
Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.The Journal of pharmacology and experimental therapeutics, 297 2
M. Demeule, J. Jodoin, D. Gingras, R. Béliveau (2000)
P‐glycoprotein is localized in caveolae in resistant cells and in brain capillariesFEBS Letters, 466
Deborah Brown, E. London (1998)
Functions of lipid rafts in biological membranes.Annual review of cell and developmental biology, 14
G. Luker, C. Pica, A. Kumar, D. Covey, D. Piwnica-worms (2000)
Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains.Biochemistry, 39 26
Caroline Lee, M. Gottesman, C. Cardarelli, M. Ramachandra, K. Jeang, S. Ambudkar, I. Pastan, S. Dey (1998)
HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.Biochemistry, 37 11
Molecular Pharmacology – Pubmed
Published: Dec 6, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.